Wang Lab

Home » 2024

Yearly Archives: 2024

Biomimetic Materials to Fabricate Artificial Cells

Congratulations to the team! In this Chemical Reviews, we have reviewed the development of cell and bionic strategies and focused on the efforts of bottom-up strategies in artificial cell construction. Different from starting with existing living organisms, we have also discussed the construction of artificial cells based on biomimetic materials, from simple cell scaffolds to multiple compartment systems, from the construction of functional modules to the simulation of crucial metabolism behaviors, or even to the biomimetic of communication networks. All of them could represent an exciting advance in the field. In addition, we will make a rough analysis of the bottlenecks in this field. Meanwhile, the future development of this field has been prospecting. This “Biomimetic Materials to Fabricate Artificial Cells” may bridge the gap between materials engineering and life sciences, forming a theoretical basis for developing various life-inspired assembly materials.

Kristal & Tessa Present at the 2024 ISU Honor Symposium

Today, two undergraduate research students from Wang Lab, Kristal Claudio & Tessa Strand, presented in the 2024 ISU Honor Program Symposium poster session. They have worked on the “Rational Design of Oral Drugs Targeting Mucosa Delivery” project. Congratulations!

New publication in Biofabrication

Working with our former lab member, Dr. Haisheng Peng, we published a new paper in Biofabrication. In this new manuscript, “3D Printing Processes in Precise Drug Delivery for Personalized Medicine”, we systematically introduce the applications of 3D Printing technologies in the pharmaceutical industry and summarize the virtues and shortcomings of each technique. Biofabrication is the leading journal focusing on cutting-edge research in biomanufacturers, biological systems, and therapeutic products. Congratulations to the team!

Illustration of Engineering Components of 3D Printing Processes in Precise Drug Delivery for Personalized Medicine.